CTTN amplification and overexpression predict poor prognosis and immunotherapy resistance in head and neck squamous cell carcinoma.

Pandi A, Jayaseelan VP, Arumugam P

Open source

DOI
10.1016/j.jormas.2026.103081
Published
2026 Nov 8
Container
Journal of stomatology, oral and maxillofacial surgery
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jormas.2026.103081,
  title = {CTTN amplification and overexpression predict poor prognosis and immunotherapy resistance in head and neck squamous cell carcinoma.},
  author = {Pandi A and Jayaseelan VP and Arumugam P},
  year = {2026},
  journal = {Journal of stomatology, oral and maxillofacial surgery},
  doi = {10.1016/j.jormas.2026.103081},
  url = {https://doi.org/10.1016/j.jormas.2026.103081}
}

RIS

TY  - JOUR
TI  - CTTN amplification and overexpression predict poor prognosis and immunotherapy resistance in head and neck squamous cell carcinoma.
AU  - Pandi A
AU  - Jayaseelan VP
AU  - Arumugam P
PY  - 2026
JO  - Journal of stomatology, oral and maxillofacial surgery
DO  - 10.1016/j.jormas.2026.103081
UR  - https://doi.org/10.1016/j.jormas.2026.103081
ER  - 

APA

A, P., VP, J., & P, A. (2026). CTTN amplification and overexpression predict poor prognosis and immunotherapy resistance in head and neck squamous cell carcinoma.. Journal of stomatology, oral and maxillofacial surgery. https://doi.org/10.1016/j.jormas.2026.103081

Source records